Pathway Health Announces Double Listing on Frankfurt Exchange

TORONTO, December 17, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) (“pathor the “Company”), an integrated healthcare company providing products and services to patients suffering from chronic pain and related conditions, is pleased to announce that the Company’s shares have been accepted for listing on the Frankfurt Stock Exchange (“FSE”) and began trading on December 17, 2021 under the symbol “KL1“.

“A listing on the Frankfurt Stock Exchange gives Pathway Health direct access to European capital markets and an opportunity for the company to increase trading liquidity and facilitate investment by expanding our shareholder base,” it said. Ken Yoon, CEO of Pathway Health.

About the Frankfurt Stock Exchange
The Frankfurt Stock Exchange is one of the world’s largest securities trading centers. With equity turnover of approximately 90 percent, it is the largest of Germany’s seven exchanges and it is an international trade center, which is reflected in the structure of its participants. Of the approximately 200 market participants, approximately 50 percent come from countries other than Germany. The FSE facilitates advanced electronic trading, settlement and information systems, enabling it to meet the growing demands of cross-border trade.

About Pathway Health
Pathway Health is an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions. The company owns and operates nine community clinics in four provinces, where its team of health professionals work together to help patients through a variety of science-backed approaches and products, including medicinal cannabis. Pathway Health’s patient care programs use an interdisciplinary approach led by trained pain specialists, physical and occupational therapists, psychologists, nurses and other health care providers. Pathway is also the leading provider of medical cannabis services in Canada and has established itself as the leading partner with national and regional pharmacy companies for the delivery of medical cannabis services to their customers. The company is working with several pharmacies to develop Cannabis Health Products (CHPs) for the distribution of OTC products through retail pharmacies across the country following expected changes to the Cannabis Act.

For more information, visit the Pathway Health website: www.pathwayhealth.ca

Neither the TSX-V nor its Regulatory Services Provider (as that term is defined in the TSX-V policies) assumes any responsibility for the suitability or accuracy of this release.

SOURCE Pathway Health Corp.

For more information: Wayne Cockburn, president, Pathway Health Corp., (905) 505-0770, [email protected]; Dave Burwell, Vice President, The Howard Group, (403) 410-7907, [email protected]

Related Links

https://pathwayhealth.ca/